Plant-Based Food Stocks That Are Taking Wall Street By Storm

FN Media Group Presents Market Commentary   New York, NY – October 21, 2020 – Investments Continue to Pour into the Rapidly Growing Plant-Based Food Market – The demand for plant-based foods has sent the market soaring to new heights over the last year and is expected to continue upwards as consumers opt for […]

Mining Brief: Gold Demand Much Higher In Light of Economic and Pandemic Crisis

Palm Beach, FL – October 21, 2020 – Over the last decade, global demand for gold has increased constantly. Worldwide gold demand amounted to 4,356 metric tons in 2019. Demand has been noticeably higher since the Financial Crisis. Many investors look to gold in periods of market turmoil because they believe that it holds value through recessions […]

Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Billion Dollar Drug Market

Palm Beach, FL – October 21, 2020 – Cancer immunotherapy has emerged as a new avenue for revenue generation for pharmaceutical companies. Adverse effects, such as recurrence of cancer and organ failure, associated with conventional chemotherapies and rising demand for technologically advanced healthcare solutions are boosting the demand for immunotherapies. Moreover, introduction of newer drug […]

Kesselrun Intercepts 15.7 g/t Au over 5.2 m including 52.3 g/t over 1.0 m

Thunder Bay, ON – October 21, 2020 – Kesselrun Resources Ltd. (TSXV:KES) (OTCPK: KSSRF), (“Kesselrun” or the “Company”) is pleased to provide the following update on its 100% owned Huronian Gold Project.   The Company reports further results from the Fisher Zone, one of four zones tested in the 2020 Huronian drill program. All results […]

Actinium Pharmaceuticals, Inc. Awarded Grant by National Institutes of Health to Study Novel Iomab-ACT Targeted Conditioning with a CD19 CAR T-Cell Therapy

NIH grant to support first of its kind clinical trial to use Antibody Radio-Conjugate for targeted conditioning prior to CAR T-cell therapy in patients with acute lymphoblastic leukemia and diffuse large B-cell lymphoma   ARC-based targeted lymphodepletion is intended to improve CAR T-cell patient outcomes by selectively depleting immune cells, including those implicated in CAR […]